RecruitingNot ApplicableNCT05340348

Patientheque in Patients With a Psychosis .

Formation of a Patientheque in Patients With a Beginner Psychosis .


Sponsor

University Hospital, Brest

Enrollment

250 participants

Start Date

Jul 25, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Establishment of a patient library for patients who have had a first psychotic episode and who have an "at risk" status for psychotic disorder (GRD, APS, BLIPS group) or a psychosis threshold during CAARMS administration. Samples are taken on inclusion, at 2 years, and if relapse or significant clinical event within 5 years of inclusion, on 250 patients for 10 years.


Eligibility

Min Age: 15 YearsMax Age: 30 Years

Inclusion Criteria3

  • Major and or minor aged 15 to 30 assessed within the CEVUP (Consultation for the Assessment of Psychological Vulnerability) and cared for at the psychiatry center as part of a first psychotic episode (Diagnosis CIM 10: F20 -F29 first hospitalization). These patients are referred by care and medico-social partners (general practitioners, school doctors, school nurses, educators, addictologists, psychiatrists
  • "At risk" status for psychotic disorder (GRD, APS, BLIPS group) or psychosis threshold during the CAARMS test (psychometric scale for the assessment of psychotic symptoms)
  • Consent of the patient or his legal guardian

Exclusion Criteria5

  • History of psychosis for more than one year
  • "Not at risk" status for psychotic disorder on the CAARMS (psychometric scale for the assessment of psychotic symptomatology)
  • IQ\<70 (WAIS)
  • Neurological disorder or other health problem that may explain the disorders
  • Refusal to participate - History of psychosis for more than one year

Interventions

OTHERBlood samples (36 mL) + fecal samples + hair sample

Blood samples at inclusion, 2 years later and/or if relapse, fecal samples at inclusion and every years for 5 years, hair sample at inclusion


Locations(1)

Chu Brest

Brest, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05340348


Related Trials